Mission Wealth Management LP boosted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 45,608 shares of the company’s stock after purchasing an additional 873 shares during the period. Mission Wealth Management LP’s holdings in Procter & Gamble were worth $6,683,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Naples Money Management LLC purchased a new stake in Procter & Gamble during the fourth quarter worth about $29,000. Wyrmwood Management LLC acquired a new position in Procter & Gamble during the fourth quarter worth about $29,000. Criterion Capital Advisors LLC acquired a new position in Procter & Gamble during the fourth quarter worth about $33,000. Mendota Financial Group LLC raised its position in Procter & Gamble by 636.6% during the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock worth $44,000 after acquiring an additional 261 shares during the last quarter. Finally, Morton Brown Family Wealth LLC raised its position in Procter & Gamble by 206.6% during the fourth quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock worth $61,000 after acquiring an additional 281 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG traded up $1.54 on Tuesday, reaching $163.20. The company had a trading volume of 8,105,405 shares, compared to its average volume of 6,942,727. The company has a fifty day moving average of $159.72 and a 200-day moving average of $153.78. The company has a market capitalization of $385.17 billion, a P/E ratio of 26.52, a PEG ratio of 3.27 and a beta of 0.44. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.47%. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.
Insider Activity
In other news, insider Susan Street Whaley sold 3,865 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total value of $620,719.00. Following the transaction, the insider now directly owns 11,886 shares of the company’s stock, valued at $1,908,891.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total value of $620,719.00. Following the sale, the insider now owns 11,886 shares of the company’s stock, valued at approximately $1,908,891.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,865 shares of company stock worth $9,009,280. Corporate insiders own 0.17% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a research report on Thursday, January 18th. Stifel Nicolaus boosted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Barclays boosted their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the company an “overweight” rating in a research report on Tuesday, April 23rd. Finally, UBS Group upped their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $169.76.
Check Out Our Latest Report on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- About the Markup Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Ride Out The Recession With These Dividend Kings
- Hilton Demonstrates Asset Light is Right for Investors
- How to Read Stock Charts for Beginners
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.